Laura Y Park-Wyllie

Summary

Publications

  1. doi Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women
    Laura Y Park-Wyllie
    Institute for Clinical Evaluative Sciences, and Li Ka Shing Knowledge Institute of St Michael s Hospital, 30 Bond St, Toronto, Ontario, M5B 1W8
    JAMA 305:783-9. 2011
  2. ncbi Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection
    Tony Antoniou
    Inner City Health HIV Program, Toronto, Ontario, Canada
    Pharmacotherapy 23:29-43. 2003
  3. ncbi Outpatient gatifloxacin therapy and dysglycemia in older adults
    Laura Y Park-Wyllie
    Institute for Clinical Evaluative Sciences, St Michael s Hospital, Toronto
    N Engl J Med 354:1352-61. 2006
  4. pmc Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs
    Peter C Austin
    Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Institute of Health Management, Policy and Evaluation, University of Toronto, Toronto, Ontario, Canada Schulich Heart Research Program, Sunnybrook Research Institute, Toronto, Canada
    Pharmacoepidemiol Drug Saf 23:819-29. 2014
  5. ncbi Outcomes of dosage adjustments used to manage antiretroviral drug interactions
    Laura Y Park-Wyllie
    Centre for Research on Inner City Health, The Keenan Research Centre in the Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada
    Clin Infect Dis 45:933-6. 2007

Detail Information

Publications5

  1. doi Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women
    Laura Y Park-Wyllie
    Institute for Clinical Evaluative Sciences, and Li Ka Shing Knowledge Institute of St Michael s Hospital, 30 Bond St, Toronto, Ontario, M5B 1W8
    JAMA 305:783-9. 2011
    ..Oral bisphosphonates have become a mainstay of treatment, but concerns have emerged that long-term use of these drugs may suppress bone remodeling, leading to unusual fractures...
  2. ncbi Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection
    Tony Antoniou
    Inner City Health HIV Program, Toronto, Ontario, Canada
    Pharmacotherapy 23:29-43. 2003
    ..Given the ease of administration and relative safety from the perspectives of adverse effects and drug interactions, tenofovir has the potential to assume a large role in the treatment of patients with HIV infection...
  3. ncbi Outpatient gatifloxacin therapy and dysglycemia in older adults
    Laura Y Park-Wyllie
    Institute for Clinical Evaluative Sciences, St Michael s Hospital, Toronto
    N Engl J Med 354:1352-61. 2006
    ..We examined dysglycemia-related health outcomes associated with various antibiotics in a population of approximately 1.4 million Ontario, Canada, residents 66 years of age or older...
  4. pmc Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs
    Peter C Austin
    Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Institute of Health Management, Policy and Evaluation, University of Toronto, Toronto, Ontario, Canada Schulich Heart Research Program, Sunnybrook Research Institute, Toronto, Canada
    Pharmacoepidemiol Drug Saf 23:819-29. 2014
    ..The Cox proportional hazards regression model can incorporate time-dependent covariates. An important class of continuous time-dependent covariates is that denoting cumulative duration of exposure...
  5. ncbi Outcomes of dosage adjustments used to manage antiretroviral drug interactions
    Laura Y Park-Wyllie
    Centre for Research on Inner City Health, The Keenan Research Centre in the Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada
    Clin Infect Dis 45:933-6. 2007
    ..03 log10 copies/mL; 95% confidence interval, -0.71 to 0.77) or nevirapine-based interactions (difference in viral load, 0.09 log10 copies/mL; 95% confidence interval, -0.83 to 1.01)...